If You Had Bought Karyopharm Therapeutics (NASDAQ:KPTI) Stock Five Years Ago, You'd Be Sitting On A 71% Loss, Today

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) shareholders should be happy to see the share price up 21% in the last…